Filter
Private equity investment in life sciences sector
Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.
4 von 6 Insights
Licensing out: Try not to get benched
Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents
IP: Licensing and insolvency
Patent law in emergency situations
UK increases scrutiny of tech and life sciences deals
Mergers and acquisitions in the tech and life sciences sectors may be subject to closer scrutiny by the UK competition authority and by the UK government in future.
6 von 6 Insights
US buys up entire stock of remdesivir
Time to intervene?
Legal advice privilege: where are we now?
Arbitration for life sciences companies